ATE253062T1 - 4- und 5-alkynyloxindole sowie 4- und 5- alkenyloxindole - Google Patents

4- und 5-alkynyloxindole sowie 4- und 5- alkenyloxindole

Info

Publication number
ATE253062T1
ATE253062T1 AT99957341T AT99957341T ATE253062T1 AT E253062 T1 ATE253062 T1 AT E253062T1 AT 99957341 T AT99957341 T AT 99957341T AT 99957341 T AT99957341 T AT 99957341T AT E253062 T1 ATE253062 T1 AT E253062T1
Authority
AT
Austria
Prior art keywords
alkynyloxindoles
alkenyloxindoles
protein kinases
inhibit
useful
Prior art date
Application number
AT99957341T
Other languages
English (en)
Inventor
Kin-Chun Luk
Paige E Mahaney
Steven Gregory Mischke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE253062T1 publication Critical patent/ATE253062T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99957341T 1998-12-17 1999-12-07 4- und 5-alkynyloxindole sowie 4- und 5- alkenyloxindole ATE253062T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11258998P 1998-12-17 1998-12-17
US14148299P 1999-06-29 1999-06-29
PCT/EP1999/009578 WO2000035906A2 (en) 1998-12-17 1999-12-07 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles

Publications (1)

Publication Number Publication Date
ATE253062T1 true ATE253062T1 (de) 2003-11-15

Family

ID=26810125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957341T ATE253062T1 (de) 1998-12-17 1999-12-07 4- und 5-alkynyloxindole sowie 4- und 5- alkenyloxindole

Country Status (14)

Country Link
EP (1) EP1149092B1 (de)
JP (1) JP2002532490A (de)
KR (1) KR20010087421A (de)
CN (1) CN1147486C (de)
AT (1) ATE253062T1 (de)
AU (1) AU771599B2 (de)
BR (1) BR9916272A (de)
CA (1) CA2354510A1 (de)
DE (1) DE69912479T2 (de)
DK (1) DK1149092T3 (de)
ES (1) ES2209527T3 (de)
PT (1) PT1149092E (de)
TR (1) TR200101747T2 (de)
WO (1) WO2000035906A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
JP2003535847A (ja) 2000-06-02 2003-12-02 スージェン・インコーポレーテッド 蛋白質キナーゼ/ホスファターゼ阻害剤としてのインドリノン誘導体
JP2004502686A (ja) 2000-06-30 2004-01-29 スージェン・インコーポレーテッド 4−ヘテロアリール−3−ヘテロアリーリデニル−2−インドリノンおよび蛋白質キナーゼ阻害剤としてのその使用
CN1300116C (zh) 2001-04-16 2007-02-14 卫材株式会社 1h-吲唑化合物
US7018999B2 (en) 2001-05-16 2006-03-28 Cephalon, Inc. Methods for the treatment and prevention of pain
AU2002303892A1 (en) 2001-05-30 2002-12-09 Jingrong Cui 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
ES2318041T3 (es) 2001-07-23 2009-05-01 Laboratoires Serono Sa Derivados de arilsulfonamida como inhibidores de c-jun quinasas (jnk) n-terminales.
BR0213233A (pt) 2001-10-12 2005-01-04 Warner Lambert Co Alcinos inibidores de metaloproteinase de matriz
US6962922B2 (en) 2001-10-12 2005-11-08 Warner-Lambert Company Llc Alkynylated quinazoline compounds
DE60332215D1 (de) 2002-02-28 2010-06-02 Eisai R&D Man Co Ltd Neue indazolverbindungen mit kondensiertem ring
US6747147B2 (en) 2002-03-08 2004-06-08 Warner-Lambert Company Oxo-azabicyclic compounds
US6894057B2 (en) 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
CA2482838A1 (en) 2002-05-31 2003-12-11 Eisai Co., Ltd. Pyrazole compounds and pharmaceutical compositions containing the compound
EP1527070B1 (de) 2002-06-14 2013-01-09 Merck Serono SA Azolmethylidencyanid-derivate und ihre verwending als proteinkinase-modulatoren
JP2007509173A (ja) 2003-10-24 2007-04-12 シエーリング アクチエンゲゼルシャフト インドリノン誘導体類及び疾病状態、例えば癌の処理へのそれらの使用
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
US7803824B2 (en) 2004-10-29 2010-09-28 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US20060094753A1 (en) 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
WO2006090698A1 (ja) * 2005-02-22 2006-08-31 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
RU2008112691A (ru) 2005-10-03 2009-10-10 Оно Фармасьютикал Ко., Лтд. (Jp) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
FR2962733B1 (fr) 2010-07-13 2012-08-17 Michelin Soc Tech Polymere greffe par des molecules associatives azotees.
FR2962729B1 (fr) 2010-07-13 2012-09-21 Arkema France Molecules porteuses de groupes associatifs
WO2012178015A2 (en) * 2011-06-24 2012-12-27 Zenobia Therapeutics, Inc. Lrrk2 inhibitors
EP3828013B1 (de) 2019-11-27 2023-09-27 Industrial Technology Research Institute Selbstgetriebene erfassungs- und übertragungsvorrichtung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
WO1998007695A1 (en) * 1996-08-23 1998-02-26 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
EP0984930B1 (de) * 1997-05-07 2005-04-06 Sugen, Inc. 2-indolinonderivate als modulatoren der proteinkinase-ativität

Also Published As

Publication number Publication date
CA2354510A1 (en) 2000-06-22
AU771599B2 (en) 2004-03-25
BR9916272A (pt) 2001-09-04
KR20010087421A (ko) 2001-09-15
WO2000035906A3 (en) 2000-11-09
EP1149092B1 (de) 2003-10-29
ES2209527T3 (es) 2004-06-16
PT1149092E (pt) 2004-03-31
WO2000035906A2 (en) 2000-06-22
CN1331689A (zh) 2002-01-16
CN1147486C (zh) 2004-04-28
DK1149092T3 (da) 2004-02-23
DE69912479T2 (de) 2004-07-22
JP2002532490A (ja) 2002-10-02
AU1507600A (en) 2000-07-03
EP1149092A2 (de) 2001-10-31
TR200101747T2 (tr) 2001-11-21
DE69912479D1 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
ATE253062T1 (de) 4- und 5-alkynyloxindole sowie 4- und 5- alkenyloxindole
BR9916223A (pt) 4-ariloxindóis como inibidores de cinases de proteìna jnk
TR200102967T2 (tr) Substitüsyonlu azollar
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
BR0010220A (pt) Compostos de pirimidinona
UY27972A1 (es) Derivados de hidantoína
DE60135029D1 (de) Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
BR9805544C1 (pt) Uso de um composto.
ATE253063T1 (de) 5-ht1f-agonisten
AU2291097A (en) Novel phenanthridines substituted in the 6 position
TR200102131T2 (tr) Matrisk metaloproteinaz inhitörleri olarak 2,3,4,5-tetrahidro-1H[1,4] benzodiyazepin-3- hidroksamik asitler.
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
TR200001950T2 (tr) İkameli 2-benzilamino-2-fenil-asetamid bileşikler.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DE69915686D1 (de) Amidinoderivate und ihre verwendung als thrombin-inhibitoren
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
TR199901386T2 (en) �midazopiridazinler.
DK1204659T3 (da) Serotonerge benzofuraner
SI1377574T1 (de)
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1149092

Country of ref document: EP

REN Ceased due to non-payment of the annual fee